KIMBERLY CAMERON: Open Payments
NPI 1881938694 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 17 payments from 12 companies in 2025. Trend: 2023 $120 · 2024 $157 · 2025 $450
Food & beverage: $351Education: $99
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $99 |
| ABBVIE INC. | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Genentech USA, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
Products named: Trodelvy, IMBRUVICA, KEYTRUDA, Itovebi, LIBTAYO, Vyloy, KISQALI, TALVEY.
Industry payments across OH — which companies pay providers there.
